The FDA pulled Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in ...
Following the lead of French pharmaceutical giant Sanofi, Pfizer has agreed to settle more than 10,000 personal-injury claims ...
Sanofi will pay more than US$100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to ...
Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to ...
Sanofi will pay $100 million—or approximately $25,000 each—to roughly 4,000 claimants who filed lawsuits saying that the French company failed to warn users that its heartburn medicine Zantac ...
The first jury trial to determine whether a popular heartburn drug causes cancer began Thursday in a packed Cook County courtroom, where an Illinois woman is arguing Zantac is responsible for the ...
COOK COUNTY -- An Illinois woman's lawsuit claiming she developed colorectal cancer from taking the heartburn drug Zantac for nearly 20 years goes to trial this week - a first among many similar ...
An Illinois resident alleges in a lawsuit she developed colorectal cancer after taking Zantac, a major heartburn drug, for nearly 20 years. The suit is one of many claims made nationwide that the ...
(Corrects paragraph 2 to state that Boehringer Ingelheim is also a defendant) By Brendan Pierson April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold ...
(Adds update on trial timing in paragraph 2, Boehringer Ingelheim statement in paragraph 9) By Brendan Pierson April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug ...
By Brendan Pierson (Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago. Jury ...